围术期急性等容血液稀释的临床研究进展  

Research Progresses of Acute Normovolemic Hemodilution in Perioperative Period

作　　者：周毅娟 林汉城[2] 陆辉 

机构地区：[1]厦门市海沧医院麻醉科,福建厦门361000 [2]厦门大学附属第一医院麻醉科,福建厦门361000

出　　处：《医学综述》2017年第13期2588-2592,共5页Medical Recapitulate

摘　　要：急性等容血液稀释(ANH)作为一种操作简单、经济实用、并具有改善微循环灌注,减少异体输血及其可能导致的一系列并发症的发生等优点的围术期血液保护措施,目前已广泛应用于临床治疗工作中。然在临床医疗实践过程中围术期急性等容血液稀释虽能安全且有效地减少术中失血量和同种异体输血量,但也发现其存在一定的应用局限性,因此需进一步探讨和综合分析ANH在临床上的安全性和有效性,及其对麻醉的影响等相关问题,以此达到血液保护的最佳效果。Acute normovolemic hemodilution（ANH） is an effective blood protection measure, with the advantages of easy operation,low cost, which can improve microcirculation perfusion, reduce the need for homologous blood transfusion and the incidence of possible complications. In recent years, it has been widely used in clinical. However, though ANH can effectively reduce the intraoperative blood loss and allogeneic transfusion,there are still many limitations in the clinical application. It is necessary to further investigate and comprehensively analyze the safety, effectiveness and influence on anesthesia of ANH in clinical, in order to uveacg the best blood protection effect.

关 键 词：急性等容血液稀释 血液保护 自体输血 异体输血 

分 类 号：R457.1[医药卫生—治疗学]